Kepos Capital LP Amgen Inc Transaction History

Kepos Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $691,600 - $917,251	-3,795 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $257,325 - $330,752	-1,360 Reduced 26.38%	3,795 $915,000
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $897,537 - $1.08 Million	5,155 New	5,155 $998,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $5.55 Million - $6.48 Million	-31,117 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $4.14 Million - $4.67 Million	22,362 Added 255.42%	31,117 $6.45 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $1.45 Million - $1.63 Million	8,755 New	8,755 $1.62 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $4.59 Million - $5.37 Million	-27,104 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $3.99 Million - $4.46 Million	23,637 Added 681.77%	27,104 $4.71 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $579,994 - $662,197	3,467	3,467 $646,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.